|
Simplify Health Care ETF | PINK | Gotham Enhanced 500 ETF | GSPY | Robo Global® Healthcare Technology and Innovation ETF | HTEC | Global X MLP ETF | MLPA | US Treasury 10 Year Note ETF | UTEN | Global X Genomics & Biotechnology ETF | GNOM | Goose Hollow Tactical Allocation ETF | GHTA | US Treasury 2 Year Note ETF | UTWO | Berkshire Hathaway Inc | BRK.B | Global X Blockchain ETF | BKCH |
Gross Expense Ratio*
0.50%
SEC 30 Day Yield (as of 12/31/22 )
0.37%
Ann. Dividend/Yield
$0.113/0.43%
Ex-Dividend Date
12/27/2022
52-Wk Range
22.79 - 28.46
Fund Inception
10/07/2021
|
 Loading...
The chart is currently unavailable.
|
The investment seeks long-term capital appreciation.Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-2.40% |
-2.55% |
-2.40% |
-2.55% |
3-Month |
+12.10% |
+12.28% |
+12.10% |
+12.28% |
6-Month |
+8.30% |
+8.50% |
+8.30% |
+8.50% |
Year-to-date |
-4.41% |
-4.27% |
-4.41% |
-4.27% |
1-Year |
-4.41% |
-4.27% |
-4.41% |
-4.27% |
3-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
+5.58% |
+5.65% |
+5.58% |
+5.65% |
Inception Date: October 07, 2021
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-4.41% |
-4.27% |
-4.41% |
-4.27% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
+5.58% |
+5.65% |
+5.58% |
+5.65% |
Inception Date: October 07, 2021
Cyclical |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Defensive |
100.00% |
0.00% |
100.00% |
0.00% |
Sensitive |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Portfolio Details
|
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|